ROPINIROLE HYDROCHLORIDE | A079229 | ORBION PHARMACEUTICALS PRIVATE LTD
Highest NADAC/Unit
$0.0832
per ea
Lowest NADAC/Unit
$0.0430
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69452036220ROPINIROLE HCL 5 MG TABLET | $0.0832 | EA | Generic | — | 2026-08-19 |
| 69452036120ROPINIROLE HCL 4 MG TABLET | $0.0818 | EA | Generic | — | 2026-08-19 |
| 69452036020ROPINIROLE HCL 3 MG TABLET | $0.0806 | EA | Generic | — | 2026-08-19 |
| 69452035920ROPINIROLE HCL 2 MG TABLET | $0.0664 | EA | Generic | — | 2026-08-19 |
| 69452035820ROPINIROLE HCL 1 MG TABLET | $0.0488 | EA | Generic | — | 2026-08-19 |
| 69452035620ROPINIROLE HCL 0.25 MG TABLET | $0.0456 | EA | Generic | — | 2026-08-19 |
| 69452035720ROPINIROLE HCL 0.5 MG TABLET | $0.0430 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.